簡要描述:新生兒檢測(cè)用紙 Neonatal Screeningwhatman樣本收集紙903號(hào)濾紙903濾紙903紙 Whatman 提供一系列用于新生兒檢測(cè)的產(chǎn)品。這些產(chǎn)品還可應(yīng)用于醫(yī)學(xué)檢驗(yàn)
產(chǎn)品分類
Product Category詳細(xì)介紹
品牌 | Whatman/英國 |
---|
whatman樣本收集紙903號(hào)濾紙903濾紙903紙
新生兒檢測(cè)用紙 Neonatal Screeningwhatman樣本收集紙903號(hào)濾紙903濾紙903紙
Whatman
提供一系列用于新生兒檢測(cè)的產(chǎn)品。這些產(chǎn)品還可應(yīng)用于醫(yī)學(xué)檢驗(yàn)
For Body Fluid Sample Collection & Transport
Since Dr. Robert Guthrie first published procedures for screening newborns for
Phenylketonuria (PKU), the 903 specimen collection paper has been the
international standard for body fluid sample collection, transport, analysis and
archiving.
The 903 paper, an FDA-registered in vitro Class II medical device, is used in
virtually all U.S. newborn screening programs and in most newborn screening
programs throughout the world. Widespread testing for phenylketonuria (PKU) has
lead to early detection and intervention for tens of thousands of babies in the
U.S. Newborn screening programs today screen for, depending on the state,
anywhere from three to eleven or more analytes, including congenital
hypothyroidism, galactosemia, branched-chain ketonuria, maple sugar urine
disorder and sickle-cell anemia. More recently, with the advent of tandem mass
spectrometry technology, many programs are adding less frequently occurring
disorders to their panel of analytes, including MCAD, cystic fibrosis and a
range of amino acid disorders.
Guaranteed consistency
Whatman maintains statistical process control (SPC) over the manufacture of 903
specimen collection paper. State-of-the-art equipment ensures uniformity and
adherence to specified parameter ranges. Since the stability of the collected
sample can be affected by the composition of the paper, Whatman carefully
controls the manufacturing process to ensure consistent omposition, uniform
thickness, flow-rate, absorbency and purity.
Manufacturing quality assurance
The 903 paper is manufactured from 100% pure cotton linters with no wet-
strength additives. Whatman guarantees to the newborn screening community that
each lot of paper that is manufactured will last for at least 12 months at
current usage levels.
Since it is a medical device, 903 paper is manufactured and tested according to
FDA Quality System Regulations and must meet a performance standard. The
critical parameters, as defined in the CLSI consensus standard for newborn
screening sample collection, are blood absorbency, serum uptake and circle size
for a specified volume of blood.
Whatman Quality Assurance tests 903 paper for blood absorbency and circle size
throughout the manufacturing run. In addition, the same tests, plus serum
uptake, are also conducted for each lot of 903 paper by an independent testing
lab and by the Centers for Disease Control Newborn Screening Quality Assurance
Program. Only when all test results confirm that of lot of 903 paper meets the
CLSI specifications is that lot released for use for specimen collection.
Post-printing quality assurance
For most applications, the 903 paper is printed and provided as part of a form
that includes detailed demographic information about the patient being tested.
The process for the printing of specimen collection paper to be used for
neonatal screening is strictly defined in the NCCLS standard. Improper printing
can calender or crush the paper, negatively impacting its absorption
characteristics. This can result in unacceptably long absorption times,
"layering" of blood spots and incomplete absorption. Because of this, Whatman
Quality Assurance tests a random sampling of forms from all printed collection
form lots for blood absorption time, circle size, and caliper. A certificate of
analysis is available upon request for each lot of printed blood collection
forms.
Beyond neonatal testing
While initially used for newborn screening from dried blood spots (DBS), 903
paper is now also widely used for the collection of many types of samples,
including collection of blood samples for HIV, HCV and hemoglobin A1c testing.
In addition, there are a number of tests that incorporate 903 paper for
physician office collection of samples that are then sent to a central
laboratory for analysis, e.g., blood lead-level monitoring. The 903 paper is
ideal medium on which to collect samples for epidemiological studies.
> Dry Rak
Dry Rak for collection card drying
The Whatman Dry Rak is designed to accommodate multiple collection forms at one
time, safely and properly air-drying the blood specimens in a suspended
horizontal position (CLSI Document LA4-A3, vol. 17 No. 16). The Dry Rak is
easily assembled, and can be affixed to a wall or counter top with optional
velcro stickers.
Whatman offers a variety of generic collection cards that meet the requirements
for many sampling programs.
> Multipart Neonatal Card
Multiple-part Neonatal Card
The multipart neonatal card includes a demographic portion in duplicate where
information about the newborn, parents, physician and care can be entered. Each
card has a unique sequential number and bar code. The tipped-on 903 collection
paper is imprinted with five 1/2" circles and has a wrap-around cover to protect
the 903 paper before and after sample collection. Each circle holds 75- 80 μL of
blood.
903 Protein Saver? card
The sample collection area of the 903 Protein Saver Card contains five
one-half-inch circles. Each circle holds 75-80 μL of sample. Wraparound cover
has spaces for name and date of collection, and is imprinted with the universal
biohazard symbol in conformance with USPS regulations. It carries the CE mark
for the European Union and fits into Whatman foil barrier ziplock bags for
storage.
Protein Saver snap-apart card
The 903 paper in this device, imprinted with four one-half-inch circles, is
enclosed between two pieces of cover stock. Each circle holds 75-80 μl of
sample. To use, one cover is snapped off, the sample is collected and the
remaining cover is folded over the sample. This cover is imprinted with the
universal biohazard symbol in conformance with USPS regulations.
Regulation Disclaimer - CE mark
Under regulations that went into effect in December 2003, specimen collection
cards, including neonatal screening cards, which are to be used for human
diagnostic tests, are classified as "other" IVD devices under the European IVD
Directive and require the CE mark if sold within the European Union. All 903
specimen collection devices manufactured and printed by Whatman for human
diagnostic testing in the EU undergo post-printing quality control and carry the
CE mark. Whatman will assume no responsibility for the quality or performance of
903 collection devices converted, printed or packaged by third party suppliers.
Training materials
Educational materials illustrating the proper method for collecting neonatal
samples are available from Whatman in six languages: English, German, French,
Italian, Spanish and Brazilian Portuguese. Please contact our technical
specialists.
Ordering Information - 903? Specimen Collection Paper
DescriptionQuantity/PackCatalogue Number
903 Protein Saver Card10010 534 612
903 Multiple-part Neonatal Card10010 537 279
903 Protein Saver? Card (EU)10010 531 018
903 Protein Saver Snap-apart Card10010 534 320
903 - 210 x 297mm10010 535 097
903 - 460 x 570mm10010 538 017
903 - 580 x 580mm10010 538 018
Desiccant packs10010 548 234
Foil-barrier ziplock bags10010 534 321
Plastic Ziploc? storage bags 4 inches x 6 inches10010 548 232
Glassine envelopes 3 1/4 inches x 4 7/8 inches10010 548 236
Biohazard labels 7/8 inches x 7/8 inches100010 534 150
Dry Rak (with velcro)1010 539 521
Dry Rak (without velcro)1010 537 173
Hand punch, 3.1 mm110 495 010
GE Whatman濾紙濾膜產(chǎn)品一級(jí)代 理(一),其余目錄見下方
WHATMAN離心超濾管
WHATMAN提取套管圓筒濾紙萃取套管
whatman 微生物檢測(cè)系統(tǒng)
WHATMAN擦鏡紙
WHATMAN盤式濾器
WHATMAN囊式濾器
WHATMAN針頭濾器
whatman定性濾紙
whatman定量濾紙
whatman玻璃纖維濾紙GF/A GF/B GF/C GF/D GF/F
whatman聚碳酸酯膜
whatman無機(jī)膜
whatman膜容器過濾器
whatman煙草檢測(cè)濾紙劍橋?yàn)V片
whatman PH試紙
DE-52纖維素
Whatman醋酸纖維素膜硝酸纖維素膜混酯膜再生纖維素膜
產(chǎn)品咨詢
電話
微信掃一掃